MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/stcltm/szae026

Медицинская библиотека · Stem cells translational medicine · 2024

Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial.

Tesch Ricardo de Souza, Takamori Esther Rieko, Menezes Karla, Carias Rosana Bizon Vieira, Rebelatto Carmen Lucia Kuniyoshi, Senegaglia Alexandra Cristina, Daga Debora Regina, Fracaro Leticia, Robert Anny Waloski, Pinheiro Carlos Bruno Reis, Aguiar Marcelo de Freitas, Blanco Pablo Javier, Zilves Eduardo Guerreiro, Brofman Paulo Roberto Slud, Borojevic Radovan

СтатьяКлиническое исследование II фазыКлиническое исследование I фазыПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Condylar resorption is an aggressive and disability form of temporomandibular joint (TMJ) degenerative disease, usually non-respondent to conservative or minimally invasive therapies and often leading to surgical intervention and prostheses implantation. This condition is also one of the most dreaded postoperative complications of orthognathic surgery, with severe cartilage erosion and loss of subchondral bone volume and mineral density, associated with a painful or not inflammatory processes. Because regenerative medicine has emerged as an alternative for orthopedic cases with advanced degenerative joint disease, we conducted a phase I/IIa clinical trial (U1111-1194-6997) to evaluate the safety and efficacy of autologous nasal septal chondroprogenitor cells. Ten participants underwent biopsy of the nasal septum cartilage during their orthognathic surgery. The harvested cells were cultured in vitro and analyzed for viability, presence of phenotype markers for mesenchymal stem and/or chondroprogenitor cells, and the potential to differentiate into chondrocytes, adipocytes, and osteoblasts. After the intra-articular injection of the cell therapy, clinical follow-up was performed using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and computed tomography (CT) images. No serious adverse events related to the cell therapy injection were observed during the 12-month follow-up period. It was found that autologous chondroprogenitors reduced arthralgia, promoted stabilization of mandibular function and condylar volume, and regeneration of condylar tissues. This study demonstrates that chondroprogenitor cells from the nasal septum may be a promise strategy for the treatment of temporomandibular degenerative joint disease that do not respond to other conservative therapies.

Для цитирования: Tesch Ricardo de Souza, Takamori Esther Rieko, Menezes Karla, Carias Rosana Bizon Vieira, Rebelatto Carmen Lucia Kuniyoshi, Senegaglia Alexandra Cristina, Daga Debora Regina, Fracaro Leticia, Robert Anny Waloski, Pinheiro Carlos Bruno Reis, Aguiar Marcelo de Freitas, Blanco Pablo Javier, Zilves Eduardo Guerreiro, Brofman Paulo Roberto Slud, Borojevic Radovan. Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial.. Stem cells translational medicine. 2024. DOI: 10.1093/stcltm/szae026.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.